Publications

January 2023
Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker

What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details

Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry

10 Oct 2018
Blog Post

6 Lessons Learned from a Summer of Entrepreneurship

As an unknown liquid dripped down my head and onto my face, I tried to keep my composure and continue our customer interview in Central Park. Melissa, my co-founder, helped me wipe my face as I wrapped up the interview. Our first day... View Details

Keywords: Entrepreneurship

29 Jan 2019
First Look

New Research and Ideas, January 29, 2019

David Grabowski, and David Cutler Abstract— Medicare’s Hospital Readmissions Reduction Program (HRRP) has been credited with lowering risk-adjusted readmission rates for targeted conditions at general acute care hospitals. However, these... View Details

Keywords: Dina Gerdeman

2021
Working Paper

Kidney Exchange: An Operations Perspective

By: Itai Ashlagi and Alvin E. Roth

Many patients in need of a kidney transplant have a willing but incompatible (or poorly matched) living donor. Kidney exchange programs arrange exchanges among such patient-donor pairs, in cycles and chains of exchange, so each patient receives a compatible kidney.... View Details

Keywords: Kidney Exchange Programs; Health Disorders; Health Care and Treatment; Programs; Design

Find at Harvard

Read Now

Web

Employment Data

Starting own business 13% Company sponsored or already employed 3% Other 1% Postponing job search 0% Continuing education 0% No Data Available Median Base Salary $175,000 Median Signing Bonus $30,000 53% Receiving Median Variable Bonus... View Details

08 Jun 2020
News

Tenants and Investors Will Be Looking for Healthy Buildings

08 May 2022
Blog Post

The Territory of Motherhood: A Reflection in Honor of Mother’s Day

have spent twenty days in the NICU watching our babies become strong enough to come home. All of our first interactions have been tangled with cords and closely watched by wonderful nurses as we grew the confidence to care for our tiny... View Details

Research Summary

AIDS in Africa: Life, Death and Property Rights

By: Debora L. Spar

In the final years of the twentieth century, the world was hit by a plague of epidemic proportions--the plague of AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought... View Details

12 May 2020
News

Coronavirus and the future of the workplace: 8 trends to watch

Web

Faculty & Research

an early-withdrawal penalty of 1 . When households have heterogeneous present bias, the social optimum is well approximated by a two-account system: (i) an account that is completely liquid and (ii) an account that is completely illiquid until retirement. Health View Details

June 2023
Case

Verve Therapeutics: Taking DNA Editing to Heart

By: Shikhar Ghosh and Shweta Bagai

Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details

Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry

15 Sep 2020
News

Fitbit Atrial Fibrillation Approval Revs Up Competition With Apple Watch

Nitin Nohria

Nitin Nohria served as the tenth dean of Harvard Business School from 2010-2020. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and Head of the Organizational Behavior unit.

As Dean, building on... View Details

October 2022
Case

Afrigen Biologics: Vaccines for the Global South

By: Debora L. Spar and Julia Comeau

The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details

Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa